✦ LIBER ✦

P09.1 Everolimus therapy for subependymal giant-cell astrocytomas (SEGAs) associated with tuberous sclerosis complex (TSC) following surgical resection and tumor recurrence

✍ Scribed by D.N. Franz; K.D. Agrícola; C.A. Tudor; D.A. Krueger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P09.4 Everolimus therapy shows dose prop

✍ D.A. Krueger; T. Sahmoud; W. Cheung; K.D. Agricola; C.A. Tudor; D.N. Franz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

P240 – 1817 Safety of long-term everolim

✍ Jozwiak, S; Kotulska, K; Chmielewski, D; Borkowska, J; Łojszczyk, B; Kuczyński, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

P239 – 1816 Safety of everolimus by age

✍ Jozwiak, S; Brechenmacher, T; Segal, S; Franz, DN 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

PP6.0 – 1815 Everolimus for subependymal

✍ Jozwiak, S; Brechenmacher, T; Segal, S; Franz, DN 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Everolimus in Subependymal Giant Cell As

✍ M. Bebin; D.N. Franz; T. Sahmoud; E. Belousova; S. Sparagana; M. Frost; J. Ford; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Efficacy and safety of everolimus for su

✍ Franz, David Neal; Belousova, Elena; Sparagana, Steven; Bebin, E Martina; Frost, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 470 KB